State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure

Author(s): Mohammed Al-Sadawi*, Romy R. Ortega, Jonathan Ariyaratnam, Ayman Battisha, Bader Madoukh, Inna Bukharovich

Journal Name: Current Cardiology Reviews

Volume 17 , Issue 5 , 2021

Article ID: e230421189012
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Heart failure (HF) affects an increasing number of geriatric patients. The condition is classified according to whether the left ventricular ejection fraction (EF) is reduced or preserved. Many patients have heart failure with preserved ejection fraction (HFpEF) and face a shortage of effective therapeutic strategies. However, an emerging mechanical strategy for treatment is gaining momentum. Interatrial septal connection devices, i.e. V-wave device and Interatrial septal device, are new devices for patients with heart failure with preserved ejection fraction. We review the function of these systems and the data from the recent clinical trials.

Interatrial septal connection device therapy provided favorable efficacy and safety profile applicable to a wide range of patients with HFpEF. However, the long-term effects of these devices on morbidity

Keywords: Interatrial device, IASD, V-wave, heart failure with preserved ejection fraction, heart failure, device treatment for heart failure.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 10 December, 2020
Article ID: e230421189012
Pages: 7
DOI: 10.2174/1573403X16999201210195455
Price: $65

Article Metrics

PDF: 492